CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-03 | Thompson Travis Alvin Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +58,000 | 58,000 | ||
| 2026-01-05 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Sale | −2,367 | $6.45 | $15K | 97,908 |
| 2026-01-05 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −1,115 | $6.45 | $7K | 66,265 |
| 2026-01-05 | Young Alethia Chief Financial Officer | Sale 10b5-1 | −2,456 | $6.45 | $16K | 88,959 |
| 2026-01-05 | Young Alethia Chief Financial Officer | Sale 10b5-1 | −1,878 | $6.54 | $12K | 87,081 |
| 2026-01-05 | Milnes Alistair CHIEF OPERATING OFFICER | Sale | −3,416 | $6.46 | $22K | 136,717 |
| 2026-01-05 | Lee Kevin CHIEF EXECUTIVE OFFICER | Sale | −10,989 | $6.46 | $71K | 618,996 |
| 2026-01-05 | Skynner Michael CHIEF TECHNOLOGY OFFICER | Sale | −3,266 | $6.46 | $21K | 161,966 |
| 2026-01-02 | Swanton Robert Charles Director | Grant or award | +3,726 | 19,213 | ||
| 2026-01-02 | Swanton Robert Charles Director | Grant or award · Stock Option (right to buy) | +7,453 | 7,453 | ||
| 2026-01-02 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Grant or award | +50,000 | 103,102 | ||
| 2026-01-02 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Sale | −2,827 | $6.80 | $19K | 100,275 |
| 2026-01-02 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2026-01-02 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Grant or award | +37,500 | 68,697 | ||
| 2026-01-02 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −1,317 | $6.80 | $9K | 67,380 |
| 2026-01-02 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2026-01-02 | Young Alethia Chief Financial Officer | Grant or award 10b5-1 | +50,000 | 94,704 | ||
| 2026-01-02 | Young Alethia Chief Financial Officer | Sale 10b5-1 | −3,289 | $6.80 | $22K | 91,415 |
| 2026-01-02 | Young Alethia Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +100,000 | 100,000 | ||
| 2026-01-02 | Sands Stephen H. Director | Grant or award | +9,500 | 26,893 |
Page 3 of 26 · 520 trades